Quick answer
How should tirzepatide be stored? Store sealed lyophilized tirzepatide at −20 °C for long-term holding (12–24 months or more), or at 2–8 °C for up to a few months. Once reconstituted with bacteriostatic water, keep it refrigerated at 2–8 °C in its box, never at room temperature, and use it within about 28 days. Do not refreeze a working vial; if a stock must last longer, freeze single-use aliquots and thaw each one once.
Two vials of tirzepatide from the same lot can produce different assay results a month later if one sat in a refrigerator door and the other stayed boxed at the back of a −20 °C freezer. Storage is an experimental variable, and it is one of the few that is entirely under the lab's control. This guide covers temperature, moisture and light for both the dry and the dissolved state, the chemistry that makes those controls necessary, and the concentration math that goes with planning a stock. For laboratory research use only; not for human consumption.
Why storage conditions directly affect research reliability
An assay measures the response to whatever intact peptide is present, not to what the label says. If a fraction of the tirzepatide in a stock has oxidized, isomerized, aggregated or stuck to the container wall, the true concentration is lower than the nominal one, and a concentration–response curve shifts accordingly. Because none of these changes is visible, the error is silent. Disciplined storage keeps nominal and actual concentration aligned, which is the foundation for comparing results across days, operators and laboratories.
Lyophilized tirzepatide: storage requirements
Temperature
Freeze-drying removes the water that hydrolysis and most other degradation reactions depend on. The colder a dry peptide is kept, the slower the residual chemistry proceeds.
| Storage scenario | Recommended temperature | Expected stability | Comment |
|---|---|---|---|
| Long-term inventory | −20 °C | 12–24+ months | Standard condition; manual-defrost freezer preferred |
| Archival reference lots | −80 °C | Multi-year | Little added advantage over −20 °C for sealed dry vials |
| Near-term use | 2–8 °C | Up to a few months | Interior shelf, boxed |
| Transit | Ambient (15–25 °C) | Days | Acceptable for sealed dry vials; cold-store on receipt |
| Heat exposure (above 30–40 °C) | Avoid | Unpredictable | Flag the lot and verify before critical use |
Moisture control
A lyophilized cake is porous and hygroscopic. If humid air reaches it, the powder takes up water and the reactions that drying had halted restart inside the vial. Three habits prevent this: leave the crimp seal intact until the day of reconstitution; let a cold vial stand sealed at room temperature for 15–30 minutes before piercing it, so condensation forms on the outside rather than the inside; and keep boxed vials in a sealed bag or container with a desiccant pouch when ambient humidity is high.
Light protection
Tirzepatide contains tryptophan, tyrosine and phenylalanine, all of which absorb ultraviolet light. Photo-oxidation of tryptophan in particular is a recognized degradation route for peptides. Clear glass vials provide no meaningful protection, so the carton or an opaque storage box does that job. Avoid window sills and brightly lit open shelving.
Reconstituted tirzepatide solution: storage requirements
Temperature for reconstituted solutions
Refrigerate at 2–8 °C as soon as the solution is clear. Choose a middle shelf: door racks swing in temperature each time the door opens, and the rear wall of some units can dip below 0 °C and freeze a vial unnoticed. Take the vial out only for the time needed to withdraw a volume, then put it straight back.
Usable window
For tirzepatide reconstituted in bacteriostatic water and stored at 2–8 °C, laboratories work to a limit of about 28 days. The basis for that figure is the preservative, not the peptide. Benzyl alcohol at 0.9% suppresses microbial growth in a container that is punctured repeatedly; antimicrobial effectiveness testing under USP <51> is how that capability is demonstrated, and USP <797> sets 28 days as the default beyond-use limit for preserved multi-use containers after first entry.
Chemical stability is a separate question, and there is no published stability study of research-grade tirzepatide in bacteriostatic water to cite. The 28-day limit should therefore be read as an upper bound. For experiments in which a few percent of concentration drift would matter, shorten the window to two or three weeks, or work from frozen aliquots. A solution made with plain sterile water has no preservative and should be used the same day or frozen in aliquots immediately. Our article does bacteriostatic water expire? covers the diluent's own shelf life.
Aliquoting strategy
Aliquoting converts one stock that is stressed many times into many portions that are each stressed once. A workable plan for a 30 mg vial reconstituted with 3 mL (10 mg/mL):
| Plan | Aliquot volume | Mass per aliquot | Number of aliquots | Storage |
|---|---|---|---|---|
| Coarse | 500 µL | 5 mg | 6 | −20 °C; thaw one, then keep it at 2–8 °C for that week's work |
| Standard | 250 µL | 2.5 mg | 12 | −20 °C or −80 °C |
| Fine | 100 µL | 1 mg | 30 (about 28 after transfer losses) | −80 °C for long studies |
Use sterile, low-protein-binding polypropylene tubes, label each one, freeze promptly, and thaw in the refrigerator or on ice. After thawing, mix by gentle inversion; do not vortex.
Tirzepatide-specific stability considerations
Tirzepatide is a 39-residue peptide amide (C225H348N48O68, ≈ 4,813.5 g/mol) carrying a C20 fatty diacid attached through a hydrophilic linker to a lysine side chain, with two α-aminoisobutyric acid (Aib) residues in the backbone. Several features of that structure bear on storage.
| Structural feature | Stability consequence | Practical control |
|---|---|---|
| C20 fatty diacid side chain | Amphiphilic molecule that self-associates and adsorbs to surfaces and air–liquid interfaces | No shaking; low-bind plastics; avoid very dilute storage stocks |
| Tryptophan and tyrosine residues | Photo-oxidation and oxidation by dissolved oxygen or peroxides | Keep dark; limit headspace air exchange |
| Aspartate residues | Isomerization and backbone cleavage at Asp, faster at acidic pH and elevated temperature | Keep cold; do not acidify stocks |
| Glutamine residues | Slow deamidation in solution | Respect the working window |
| No methionine or cysteine | Less oxidation-prone than many peptides; no disulfide scrambling | No reducing agents required |
| Aib residues | Designed to resist enzymatic cleavage; no special storage requirement | None |
For context, the manufacturer's labeling for the approved, formulated tirzepatide product specifies refrigerated storage at 2–8 °C, protection from light, no freezing, and a limited allowance for unrefrigerated storage. That product is a buffered, excipient-containing liquid in a sealed single-use device, so its limits do not transfer directly to a research vial reconstituted on the bench. What it does confirm is the general picture: tirzepatide in solution is a cold-chain material that is sensitive to light and to freezing in its liquid presentation. A bench-reconstituted solution without that formulation should be handled at least as conservatively.
Freezing deserves a specific note. The caution against freezing applies to bulk liquid in a vial or device, where slow freezing and thawing promote aggregation of lipidated peptides. Small aliquots frozen quickly and thawed once are the accepted laboratory exception for extending the life of a stock, with the understanding that some loss is possible and that a refrigerated preserved vial used within four weeks avoids the question entirely.
Concentration planning by vial size
How much diluent you add determines the concentration you store. Moderately concentrated stocks are preferable for storage, because the fraction of peptide lost to container surfaces rises as concentration falls. Concentration (mg/mL) = vial mass (mg) ÷ diluent volume (mL). The table shows a 30 mg vial, with the mass per graduation on a U-100 laboratory syringe scale (100 units = 1 mL).
| Diluent added | Concentration | Mass per 1 unit (0.01 mL) | Mass per 10 units (0.1 mL) | Units holding 1 mg |
|---|---|---|---|---|
| 1.5 mL | 20 mg/mL | 200 mcg | 2,000 mcg | 5 units |
| 2 mL | 15 mg/mL | 150 mcg | 1,500 mcg | 6.67 units |
| 3 mL | 10 mg/mL | 100 mcg | 1,000 mcg | 10 units |
| 5 mL | 6 mg/mL | 60 mcg | 600 mcg | 16.67 units |
| 6 mL | 5 mg/mL | 50 mcg | 500 mcg | 20 units |
| Vial size | 1 mL | 2 mL | 3 mL | 5 mL |
|---|---|---|---|---|
| 5 mg | 5 mg/mL | 2.5 mg/mL | 1.67 mg/mL | 1 mg/mL |
| 10 mg | 10 mg/mL | 5 mg/mL | 3.33 mg/mL | 2 mg/mL |
| 15 mg | 15 mg/mL | 7.5 mg/mL | 5 mg/mL | 3 mg/mL |
| 30 mg | 30 mg/mL | 15 mg/mL | 10 mg/mL | 6 mg/mL |
| 60 mg | 60 mg/mL | 30 mg/mL | 20 mg/mL | 12 mg/mL |
Use the reconstitution calculator for other combinations, and see tirzepatide reconstitution and handling for bench technique. One mg/mL of tirzepatide corresponds to about 208 µM.
Visual signs of degradation
| Observation | Likely cause | Action |
|---|---|---|
| Clear, colorless solution | Normal | Continue; note that clarity does not prove potency |
| Bubbles or foam right after mixing | Agitation | Let stand; swirl more gently next time |
| Persistent haze or opalescence | Aggregation or contamination | Discard |
| Visible particles, flakes or fibers | Aggregates, stopper fragments or microbial growth | Discard |
| Yellow or brown tint | Oxidation or contamination | Discard |
| Gel-like film on glass | Surface aggregation of lipidated peptide | Discard |
| Collapsed, sticky or discolored lyophilized cake | Moisture ingress or heat exposure | Quarantine; verify analytically or replace |
When a result depends on it, visual inspection is not enough. HPLC against the batch certificate is the definitive check; see tirzepatide purity testing and the COA library.
Handling temperature excursions
- Dry vial at room temperature for several days: generally acceptable; return to cold storage and note it.
- Dry vial exposed to high heat: uncertain; flag the lot and confirm purity before critical work.
- Solution on the bench for an hour or two: minor; refrigerate and shorten the remaining window.
- Solution left out overnight: replace it for any quantitative experiment.
- Working vial found frozen: thaw in the refrigerator, inspect carefully, and use only if perfectly clear, recording the event.
- Refrigerator or freezer failure: rely on a min/max thermometer or data logger; without a record, assume the worst case.
Quick-reference storage summary
| Form | Temperature | Container | Max usable window |
|---|---|---|---|
| Lyophilized, long-term | −20 °C | Original sealed vial, boxed, with desiccant | 12–24+ months |
| Lyophilized, short-term | 2–8 °C | Original sealed vial, boxed | A few months |
| Reconstituted, bacteriostatic water | 2–8 °C | Original vial, upright, dark | About 28 days |
| Reconstituted, sterile water | 2–8 °C | Original vial | Same day |
| Frozen aliquots | −20 °C | Low-bind polypropylene tubes | 1–3 months, one thaw |
| Frozen aliquots | −80 °C | Low-bind polypropylene tubes | Several months, one thaw |
| Diluted working solution | On ice during use | Assay plate or tube | Prepare fresh |
Related resources
- Tirzepatide research peptide – specifications and batch documentation
- Where to buy tirzepatide for research
- Tirzepatide research FAQ
- Retatrutide storage and stability and semaglutide storage and stability
- Storing research peptides: general principles
References
- Eli Lilly and Company. MOUNJARO (tirzepatide) prescribing information. U.S. Food and Drug Administration label.
- United States Pharmacopeia. General Chapter <797> Pharmaceutical Compounding—Sterile Preparations. USP–NF.
- United States Pharmacopeia. General Chapter <51> Antimicrobial Effectiveness Testing. USP–NF.
- United States Pharmacopeia. General Chapter <659> Packaging and Storage Requirements. USP–NF.
- International Council for Harmonisation. ICH Q1A(R2): Stability Testing of New Drug Substances and Products. 2003.
- International Council for Harmonisation. ICH Q1B: Photostability Testing of New Drug Substances and Products. 1996.
- Manning MC, Chou DK, Murphy BM, Payne RW, Katayama DS. Stability of protein pharmaceuticals: an update. Pharm Res. 2010;27(4):544-575.
- Wang W. Instability, stabilization, and formulation of liquid protein pharmaceuticals. Int J Pharm. 1999;185(2):129-188.
- Wang W. Lyophilization and development of solid protein pharmaceuticals. Int J Pharm. 2000;203(1-2):1-60.
Frequently Asked Questions
How long does lyophilized tirzepatide last?
Sealed and stored at −20 °C in the dark, lyophilized tirzepatide is generally expected to remain stable for 12 to 24 months or longer. At 2–8 °C, plan on up to a few months. Check the supplier's documentation for any lot-specific retest date.
How long does reconstituted tirzepatide last in the refrigerator?
Up to about 28 days when reconstituted with bacteriostatic water and kept at 2–8 °C away from light. That limit comes from the convention for preserved multi-use containers; for sensitive experiments, use the solution within two to three weeks.
Does tirzepatide need to be refrigerated before it is mixed?
Cold storage is recommended. The dry powder tolerates ambient shipping for days, but for anything longer it should be kept at 2–8 °C or, preferably, −20 °C.
Can reconstituted tirzepatide be stored at room temperature?
No. Room temperature accelerates hydrolysis, isomerization and aggregation. Limit time out of the refrigerator to the minutes needed for handling.
Can I freeze reconstituted tirzepatide?
Do not freeze and thaw a working vial. If longer storage is needed, divide the stock into single-use aliquots in low-bind tubes, freeze them promptly and thaw each once.
What happens if tirzepatide gets warm during shipping?
Sealed lyophilized vials are designed to tolerate short ambient transit. Extended exposure to high heat is less predictable; if you suspect it, flag the lot and confirm purity by HPLC before using it in critical experiments.
How can I tell if tirzepatide has gone bad?
Discard any solution that is hazy, contains particles, has changed color or shows a film on the glass. Because many degradation products are invisible, analytical testing is the only way to confirm that a clear solution is still within specification.
Does light damage tirzepatide?
It can. Aromatic residues such as tryptophan are susceptible to photo-oxidation. Keep vials in their carton or an opaque box in both the dry and the reconstituted state.
Is bacteriostatic water or sterile water better for storage?
Bacteriostatic water is better for any vial that will be entered more than once, because its benzyl alcohol preservative inhibits microbial growth. Sterile water is suitable only for same-day use or immediate aliquoting and freezing.
What concentration results from a 30 mg vial with 3 mL of diluent?
Thirty milligrams in 3 mL is 10 mg/mL. On a U-100 syringe scale that is 100 mcg per unit mark and 1 mg per 10 units.
Why should the vial not be shaken?
Tirzepatide carries a fatty-acid side chain that makes it surface-active. Shaking creates foam and air–liquid interfaces where the peptide aggregates. Gentle swirling or inversion is sufficient.